Epigenomic profiling of circulating chromatin for early detection and monitoring of neuroendocrine prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium.
Morning Overview on MSN
A year of added prostate-cancer therapy cut the odds the disease spreads, a major trial found
Men treated for prostate cancer after surgery now have clearer evidence that extending hormone therapy from six months to two ...
A grandfather died of prostate cancer after GPs ignored his symptoms for nine years. Terry Adams first went to his family ...
When a man receives a prostate cancer diagnosis, thoughts often race toward treatment options and survival rates. However, the recovery journey after prostate surgery represents a critical chapter ...
The journey through prostate cancer treatment marks a significant chapter in many men’s lives, with surgery often serving as a pivotal turning point toward recovery. While the removal of cancerous ...
New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors ...
A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...
Gabby Logan's husband, Kenny Logan, continues to have check-ups every six months after receiving the all-clear from prostate cancer in 2023 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results